NEW YORK (GenomeWeb News) — PerkinElmer today said it has acquired UK imaging company Improvision for an undisclosed sum.
PerkinElmer said Improvision, which makes 3D and 4D cellular-imaging software and hardware, earned about ₤6 million ($11.9 million) in 2006.
PerkinElmer CEO Gregory Summe said the all-cash purchase will allow the company to offer “a single source for imaging and analysis solutions.”
The company said the acquisition “builds upon” the high-content screening platform it acquired when it bought Evotec Technologies in December for $30 million, and that integrate Improvision’s and Evotec’s product portfolios.
With the acquisition, PerkinElmer adds the Volocity software, which captures, visualizes and analyzes cellular images, and a software system for cellular control and analysis.
PerkinElmer said the software will complement its Ultraview Live Cell Imaging systems, which it uses for high-speed, multi-dimensional imaging.